Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Afatinib × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Thoracic 1 Breast 1

Conditions

Breast Neoplasms 11 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Brain Neoplasms 1 Blast Crisis 1 Anemia 1

Interventions

Trastuzumab 16 Radiosurgery 14 Capecitabine 12 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Lapatinib 9 trastuzumab deruxtecan 7 Temozolomide 6 tucatinib 4 pembrolizumab 4 paclitaxel-Angiopep-2 conjugate 4 eribulin 4 Specimen Handling 4 Methotrexate 4 Cisplatin 4 pyrotinib 3 Vinorelbine 3 Radiation 3 Paclitaxel 3 Fluorodeoxyglucose F18 3 sacituzumab govitecan 2 pertuzumab 2 palbociclib 2 neratinib 2 durvalumab 2 cediranib 2 cabazitaxel 2 abemaciclib 2 Sodium Chloride 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02768337 2024-01-31

CamBMT1

Cambridge University Hospitals NHS Foundation Trust

Phase 1/2 Terminated

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡